Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-24-002221
Filing Date
2024-03-01
Accepted
2024-02-29 19:10:01
Documents
9
Effectiveness Date
2024-03-01

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20240229xs8.htm S-8 141210
2 EX-5.1 tmb-20240229xex5d1.htm EX-5.1 9625
3 EX-23.1 tmb-20240229xex23d1.htm EX-23.1 3814
4 EX-FILING FEES tmb-20240229xexfilingfees.htm EX-FILING FEES 33079
5 GRAPHIC tmb-20240229xex5d1001.jpg GRAPHIC 25088
6 GRAPHIC tmb-20240229xex5d1002.jpg GRAPHIC 15110
7 GRAPHIC tmb-20240229xex5d1003.jpg GRAPHIC 5643
8 GRAPHIC tmb-20240229xs8001.jpg GRAPHIC 691
9 GRAPHIC tmb-20240229xs8005.jpg GRAPHIC 879
  Complete submission text file 0001558370-24-002221.txt   254910
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Filer) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277562 | Film No.: 24706212
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)